$998 Million is the total value of Rhenman & Partners Asset Management AB's 88 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 5.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CI | Buy | Cigna Corp | $36,379,000 | +64.2% | 174,691 | +34.0% | 3.64% | +60.7% |
| CVS | Buy | CVS Health Corp | $34,548,000 | +43.6% | 438,868 | +17.4% | 3.46% | +40.6% |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $33,825,000 | +42.0% | 243,329 | +26.8% | 3.39% | +39.0% |
| VRTX | Sell | Vertex Pharmaceuticals Inc | $27,459,000 | +4.2% | 142,465 | -8.1% | 2.75% | +2.0% |
| INCY | Sell | Incyte Corp Ltd | $26,037,000 | +1.3% | 376,916 | -1.8% | 2.61% | -0.8% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $25,682,000 | +13.7% | 264,849 | +10.4% | 2.57% | +11.3% |
| ABMD | Sell | Abiomed Inc | $25,052,000 | +1.4% | 55,701 | -7.8% | 2.51% | -0.8% |
| MDT | Sell | Medtronic Plc Reg | $24,580,000 | +2.6% | 249,874 | -10.7% | 2.46% | +0.4% |
| UNH | Sell | United Health Group Inc | $24,210,000 | +2.8% | 91,000 | -5.2% | 2.43% | +0.7% |
| DPLO | Buy | Diplomat Pharmacy Inc Reg | $22,795,000 | +526.4% | 1,174,411 | +724.9% | 2.28% | +514.0% |
| EXEL | Buy | Exelixis Inc | $22,352,000 | +10.4% | 1,261,414 | +34.0% | 2.24% | +8.1% |
| JAZZ | Sell | Jazz Pharmaceuticals Plc | $21,239,000 | -4.0% | 126,322 | -1.6% | 2.13% | -6.0% |
| NVCR | Sell | NovoCure Ltd Reg | $20,960,000 | +48.8% | 400,000 | -11.1% | 2.10% | +45.6% |
| BDX | Sell | Becton Dickinson & Co | $20,880,000 | +2.5% | 80,000 | -5.9% | 2.09% | +0.4% |
| BMY | Sell | Bristol Myers Squibb Co | $20,486,000 | -15.9% | 330,000 | -25.0% | 2.05% | -17.6% |
| SGMO | Buy | Sangamo Therapeutics Inc Reg | $20,295,000 | +35.9% | 1,197,357 | +13.8% | 2.03% | +33.0% |
| ABT | Buy | Abbott Laboratories | $19,408,000 | +50.1% | 264,552 | +24.8% | 1.94% | +47.0% |
| ANTM | Sell | Anthem Inc | $19,184,000 | +6.0% | 70,000 | -7.9% | 1.92% | +3.8% |
| NKTR | Sell | Nektar Therapeutics | $18,617,000 | -38.3% | 305,393 | -50.6% | 1.86% | -39.6% |
| GKOS | Sell | Glaukos Corp | $18,255,000 | +24.8% | 281,279 | -21.9% | 1.83% | +22.2% |
| LLY | Sell | Eli Lilly & Co | $18,243,000 | +6.9% | 170,000 | -15.0% | 1.83% | +4.6% |
| HZNP | Sell | Horizon Pharma Plc | $17,956,000 | -33.6% | 917,051 | -43.8% | 1.80% | -35.0% |
| HUM | Sell | Humana Inc | $17,942,000 | -17.4% | 53,000 | -27.4% | 1.80% | -19.2% |
| SAGE | Sell | Sage Therapeutics Inc | $17,619,000 | -13.2% | 124,739 | -3.8% | 1.76% | -15.0% |
| ARNA | Buy | Arena Pharmaceuticals Inc Reg | $16,861,000 | +35.9% | 366,387 | +28.7% | 1.69% | +33.1% |
| EW | Buy | Edwards Lifesciences Corp | $16,815,000 | +69.0% | 96,585 | +41.3% | 1.68% | +65.4% |
| CELG | Sell | Celgene Corp | $16,171,000 | -3.4% | 180,698 | -14.2% | 1.62% | -5.4% |
| ESPR | Sell | Esperion Therapeutics Inc | $15,705,000 | -1.4% | 353,961 | -12.9% | 1.57% | -3.4% |
| FGEN | Buy | FibroGen Inc | $15,260,000 | +1.8% | 251,190 | +4.9% | 1.53% | -0.4% |
| ALNY | Buy | Alnylam Pharmaceuticals Inc | $15,049,000 | +34.1% | 171,950 | +50.9% | 1.51% | +31.2% |
| GILD | Sell | Gilead Sciences Inc | $14,643,000 | -21.1% | 189,647 | -27.6% | 1.47% | -22.8% |
| IOVA | Buy | Iovance Biotherapeutics Inc Reg | $14,518,000 | +33.8% | 1,290,495 | +52.3% | 1.46% | +31.1% |
| ITCI | Sell | Intra-Cellular Therapies Inc | $14,213,000 | +15.4% | 654,982 | -6.0% | 1.42% | +13.0% |
| SGEN | Sell | Seattle Genetics Inc Reg | $13,882,000 | -9.1% | 180,000 | -21.7% | 1.39% | -11.0% |
| AGN | Sell | Allergan Plc | $13,342,000 | -36.0% | 70,045 | -44.0% | 1.34% | -37.3% |
| BSX | Sell | Boston Scientific Corp | $13,012,000 | +14.4% | 337,968 | -2.9% | 1.30% | +11.9% |
| ALKS | Buy | Alkermes Plc | $12,800,000 | +7.2% | 301,610 | +4.0% | 1.28% | +5.0% |
| ABBV | Buy | AbbVie Inc | $12,295,000 | +89.6% | 130,000 | +85.7% | 1.23% | +85.5% |
| MYOK | Sell | MyoKardia Inc Reg | $12,275,000 | +24.7% | 188,272 | -5.0% | 1.23% | +22.1% |
| LIVN | Buy | Livanova Plc | $11,777,000 | +38.8% | 95,000 | +11.8% | 1.18% | +35.9% |
| ARRY | Buy | Array BioPharma Inc | $11,679,000 | -3.8% | 768,370 | +6.2% | 1.17% | -5.8% |
| AGIO | Sell | Agios Pharmaceuticals Inc | $11,215,000 | -17.0% | 145,428 | -9.3% | 1.12% | -18.7% |
| AERI | Buy | Aerie Pharmaceuticals Inc | $11,079,000 | +134.3% | 180,000 | +157.1% | 1.11% | +129.3% |
| BIIB | Buy | Biogen Inc | $10,599,000 | +180.9% | 30,000 | +130.8% | 1.06% | +175.1% |
| WBA | Sell | Walgreens Boots Alliance Inc | $10,571,000 | -46.6% | 145,000 | -56.1% | 1.06% | -47.8% |
| AET | Sell | Aetna Inc | $10,143,000 | -21.0% | 50,000 | -28.6% | 1.02% | -22.7% |
| NBIX | Sell | Neurocrine Biosciences Inc | $10,042,000 | -7.4% | 81,677 | -26.0% | 1.01% | -9.4% |
| FLXN | Buy | Flexion Therapeutics Inc | $9,969,000 | +9.6% | 532,812 | +51.5% | 1.00% | +7.3% |
| ABC | Sell | AmerisourceBergen Corp | $9,362,000 | -11.6% | 101,520 | -18.3% | 0.94% | -13.5% |
| IMMU | Sell | Immunomedics Inc | $8,860,000 | -17.8% | 425,330 | -6.6% | 0.89% | -19.5% |
| LOXO | Sell | Loxo Oncology Inc | $8,542,000 | -60.0% | 50,000 | -59.3% | 0.86% | -60.8% |
| XNCR | Sell | Xencor Inc | $8,178,000 | +2.1% | 209,854 | -3.0% | 0.82% | -0.1% |
| ONCE | Sell | Spark Therapeutics Inc | $7,511,000 | -48.9% | 137,691 | -22.5% | 0.75% | -49.9% |
| MGNX | Buy | Macrogenics Inc | $7,324,000 | +9.1% | 341,586 | +5.1% | 0.73% | +6.8% |
| OMCL | Sell | Omnicell Inc | $7,217,000 | +24.7% | 100,375 | -9.1% | 0.72% | +22.1% |
| REGN | Regeneron Pharmaceuticals Inc | $6,869,000 | +17.1% | 17,000 | 0.0% | 0.69% | +14.7% | |
| RIGL | Buy | Rigel Pharmaceuticals Inc | $6,786,000 | +40.8% | 2,113,988 | +24.1% | 0.68% | +37.9% |
| PTLA | Sell | Portola Pharmaceuticals Inc | $6,453,000 | -51.5% | 242,302 | -31.2% | 0.65% | -52.5% |
| MD | New | Mednax Inc | $5,817,000 | – | 124,674 | +100.0% | 0.58% | – |
| CNC | Sell | Centene Corp | $5,791,000 | -27.7% | 40,000 | -38.5% | 0.58% | -29.3% |
| ADMS | Sell | Adamas Pharmaceuticals Inc | $5,477,000 | -35.4% | 273,593 | -16.6% | 0.55% | -36.8% |
| CHRS | Sell | Coherus BioSciences Inc | $5,464,000 | +11.5% | 331,131 | -5.4% | 0.55% | +9.4% |
| RVNC | Revance Therapeutics Inc | $5,049,000 | -9.5% | 203,181 | 0.0% | 0.51% | -11.4% | |
| VRAY | ViewRay Inc Reg | $4,836,000 | +35.3% | 516,623 | 0.0% | 0.48% | +32.5% | |
| MDCO | Buy | Medicines Co | $4,038,000 | +0.0% | 135,000 | +22.7% | 0.40% | -1.9% |
| ZGNX | Buy | Zogenix Inc Reg | $2,976,000 | +34.7% | 60,000 | +20.0% | 0.30% | +31.9% |
| ACHN | Achillion Pharmaceuticals Inc | $2,274,000 | +30.1% | 617,800 | 0.0% | 0.23% | +27.4% | |
| PIRS | Pieris Pharmaceuticals Inc Reg | $1,680,000 | +10.5% | 300,000 | 0.0% | 0.17% | +7.7% | |
| CMRX | Sell | Chimerix Inc | $1,328,000 | -18.4% | 341,300 | -0.2% | 0.13% | -20.4% |
| PDCO | New | Patterson Companies Inc | $941,000 | – | 38,500 | +100.0% | 0.09% | – |
| ADVM | Adverum Biotechnologies Inc | $931,000 | +14.1% | 153,965 | 0.0% | 0.09% | +10.7% | |
| SNSS | Sunesis Pharmaceuticals Inc Reg | $855,000 | -5.7% | 427,642 | 0.0% | 0.09% | -7.5% | |
| XOM | Sell | Exxon Mobil Corp | $520,000 | -7.6% | 6,111 | -10.2% | 0.05% | -10.3% |
| QCOM | Sell | Qualcomm Inc | $466,000 | +14.5% | 6,476 | -10.6% | 0.05% | +11.9% |
| CVX | Chevron Corp | $456,000 | -3.4% | 3,733 | 0.0% | 0.05% | -4.2% | |
| JPM | Sell | JPMorgan Chase & Co | $420,000 | -4.8% | 3,726 | -12.0% | 0.04% | -6.7% |
| DIS | Walt Disney Co (The) | $407,000 | +11.5% | 3,483 | 0.0% | 0.04% | +10.8% | |
| PFE | Pfizer Inc | $386,000 | +21.4% | 8,754 | 0.0% | 0.04% | +18.2% | |
| HAL | Halliburton Co (Hg Co) | $374,000 | -9.9% | 9,221 | 0.0% | 0.04% | -11.9% | |
| IBM | IBM Corp | $372,000 | +8.1% | 2,461 | 0.0% | 0.04% | +5.7% | |
| BUD | Anheuser-Busch InBev SA ADR spons repr 1 Sharesponsored adr | $332,000 | -13.1% | 3,788 | 0.0% | 0.03% | -15.4% | |
| MSFT | Microsoft Corp | $330,000 | +15.8% | 2,887 | 0.0% | 0.03% | +13.8% | |
| JHG | Janus Henderson Group Plc Reg | $319,000 | -12.1% | 11,828 | 0.0% | 0.03% | -13.5% | |
| WFC | Wells Fargo & Co | $308,000 | -5.2% | 5,858 | 0.0% | 0.03% | -6.1% | |
| F | Ford Motor Co | $300,000 | -16.4% | 32,405 | 0.0% | 0.03% | -18.9% | |
| GOOGL | Alphabet Inc Acap stk cl a | $215,000 | +7.0% | 178 | 0.0% | 0.02% | +4.8% | |
| SYMC | Sell | Symantec Corp | $207,000 | -20.7% | 9,734 | -23.0% | 0.02% | -22.2% |
| RGLS | Regulus Therapeutic Inc | $97,000 | -70.2% | 492,878 | 0.0% | 0.01% | -69.7% | |
| ACAD | Exit | Acadia Pharmaceuticals Inc | $0 | – | -220,000 | -100.0% | -0.34% | – |
| JNJ | Exit | Johnson & Johnson | $0 | – | -60,000 | -100.0% | -0.74% | – |
| ESRX | Exit | Express Scripts Hg Co | $0 | – | -295,000 | -100.0% | -2.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-10-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.